(Q46391119)

21 December 2017

title

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries (English)

1 reference

21 December 2017

main subject

anti-retroviral agent

0 references

0 references

1 reference

21 December 2017

Margaret May

0 references

David R Bangsberg

1 reference

21 December 2017

Robin Wood

1 reference

21 December 2017

François Dabis

1 reference

21 December 2017

Paula Braitstein

1 reference

21 December 2017

Jonathan Sterne

object named as

Jonathan A C Sterne

1 reference

21 December 2017

Eric Balestre

object named as

Eric Balestre

1 reference

21 December 2017

author name string

Martin W G Brinkhof

1 reference

21 December 2017

Mauro Schechter

1 reference

21 December 2017

Andrew Boulle

1 reference

21 December 2017

Paolo Miotti

1 reference

21 December 2017

Christian Laurent

1 reference

21 December 2017

Eduardo Sprinz

1 reference

21 December 2017

Catherine Seyler

1 reference

21 December 2017

Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration

1 reference

21 December 2017

ART Cohort Collaboration (ART-CC) groups

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

367

1 reference

21 December 2017

issue

9513

1 reference

21 December 2017

page(s)

817-824

1 reference

21 December 2017

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Tuberculosis in HIV-infected patients: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Multiple imputation of missing blood pressure covariates in survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

The TREAT Asia HIV Observational Database: baseline and retrospective data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Antiretroviral therapy in a thousand patients with AIDS in Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

The World Bank on world health: under fire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Equity and health sector reforms: can low-income countries escape the medical poverty trap?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Explaining trends in inequities: evidence from Brazilian child health studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

Antiretroviral therapy in resource-poor settings: scaling up inequalities?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968337-2

7 January 2021

10.1016/S0140-6736(06)68337-2

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017